BFM
TRAW icon

Boothbay Fund Management’s Traws Pharma TRAW Stock Holding History

Boothbay Fund Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$356K Hold
194,536
– – ﹤0.01% 1538
2025
Q4 		$220K Buy
+194,536
New +$433K ﹤0.01% 1620
2025
Q2 		– Sell
-33,305
Closed -$76.6K – 1824
2025
Q1 		$76.6K Buy
33,305
+4,874
+17% +$25.3K ﹤0.01% 1250
2024
Q4 		$108K Buy
+28,431
New +$158K ﹤0.01% 1280
2021
Q2 		– Sell
-364
Closed -$136K – 2161
2021
Q1 		$136K Buy
+364
New +$137K 0.01% 1442

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Boothbay Fund Management's TRAW Position: Q1 2026 in Review

Boothbay Fund Management held its Traws Pharma (TRAW) position steady in Q1 2026 at 194,536 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #1538.

Boothbay Fund Management first reported a position in TRAW in Q1 2021 and has held it in 5 quarters since. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Boothbay Fund Management held 194,536 shares of Traws Pharma worth $356K as of Q1 2026.
  • Boothbay Fund Management left its Traws Pharma share count unchanged in Q1 2026.
  • Traws Pharma made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1538 holding.
  • Boothbay Fund Management first reported a position in Traws Pharma in Q1 2021 and has held it in 5 quarters since.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.